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Summary 
According to the WHO, about 10 million people fall ill with tuberculosis every year, 1.2-1.4 million of them die. 
Drug-resistant forms of tuberculosis make a significant contribution to this statistic - 483,000-639,000 new cases of mul-
tidrug-resistant (MDR-TB) and extensively drug resistant (XDR-TB) tuberculosis are recorded annually.
This study was performed to evaluate the sensitivity and specificity of molecular-genetic diagnostic method Hain 
MTBDR in comparison to cultural methods of determining M. tuberculosis drug resistance.
Materials and methods. 3527 sputum specimens from TB patients were investigated by Hain MTBDR and cultural 
methods (BACTEC and solid Lowenstein-Jensen medium) during 2018-2019.
Results. 25 inconsistencies were found between the results of Hain MTBDR and cultural methods, which accounted 
for 0.7% of all tests performed. The sensitivity of Hain MTBDR in this study was 99.7%, and specificity - 99.6%. Most 
of the inconsistencies in the results of molecular genetic and cultural research methods (12 cases) accounted for the deter-
mination of resistance to fluoroquinolones. Of these, mutations in the gyrA gene were found in 10 cases, corresponding 
to resistance to fluoroquinolones, which were not confirmed subsequently.
Conclusions. Hain MTBDR is a fast, highly sensitive, highly specific and relatively economical method for diagnos-
ing drug resistance of M. tuberculosis.
Key-words: Molecular genetic method, cultural method, chemoresistant forms of tuberculosis.
Резюме. Эффективность Hain MTBDR в определении устойчивости M. Tuberculosis к противотуберку-
лезным препаратам
Ежегодно по данным ВОЗ туберкулёзом заболевает около 10 млн. человек, 1,2-1,4 млн. из них умирают. Не-
малый вклад в данную статистику вносят химиорезистентные формы туберкулёза – ежегодно регистрируется 
483000-639000 новых случаев мультирезистентного (МРТБ) и расширенно резистентного (РРТБ) туберкулёза.
Целью данного исследования было оценить чувствительность и специфичность молекулярно-генетическо-
го метода диагностики Hain MTBDR по сравнению с культуральными методами определения устойчивости M. 
tuberculosis к противотуберкулезным препаратам.
Материалы и методы. Было обследовано 3527 образцов мокроты пациентов больных туберкулёзом, полу-
ченных в течение 2018-2019 гг., с помощью Hain MTBDR и культуральных методов исследования (в системе 
BACTEC и на среде Левенштейна-Йенсена).
Результаты. Среди обследованных образцов мокроты было найдено 25 несовпадений между результатами 
Hain MTBDR и культуральных исследований, что составило 0,7% от всех проведенных исследований. Чувстви-
тельность Hain MTBDR в данном исследовании составила 99,7%, а специфичность – 99,6%. Большинство несо-
впадений результатов молекулярно-генетических и культуральных методов исследований (12 случаев) приходи-
лось на определение устойчивости к фторхинолонам. Из них в 10 случаях были обнаружены мутации в гене gyrA, 
соответствующие устойчивости к фторхинолонам, которые впоследствии не подтвердились.
Выводы. Hain MTBDR является быстрым, высокочувствительным, высокоспецифичным и относительно эко-
номным методом диагностики лекарственной устойчивости M. tuberculosis.
Ключевые слова:  молекулярно-генетический метод, культуральный метод, химиорезистентные формы ту-
беркулёза.
Background. According to the WHO, about 10 
million people fall ill with tuberculosis every year, 
1.2-1.4 million of them die. Chemoresistant forms 
of tuberculosis make a significant contribution to 
this statistic - 483,000-639,000 new cases of multi-
drug-resistant (MDR-TB) and extensively drug resis-
tant (XDR-TB) tuberculosis are recorded annually. 
That is, approximately every 17th patient in the world 
develops multidrug-resistant or extensively drug re-
sistant tuberculosis [1]. In this regard, an important 
issue is the fastest determination of M. tuberculosis 
(MTB) drug resistance with the aim of timely initi-
ating treatment with individual regimens using sec-
ond-line drugs and preventing the expansion of drug 
resistance.
Cultural research methods (the gold standard for 
determining the resistance of MTB) are essentially 
phenotypic, so they cannot determine the resistance 
to anti-tuberculosis drugs as soon as possible. XDR-
TB diagnostics is a two-step process. In the first 
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stage, resistance to first-line drugs is determined, and 
in the second stage, resistance to second-line drugs is 
determined [2].
Over the past decade, the diagnosis of drug-re-
sistant tuberculosis has been significantly improved 
with the introduction of molecular genetic research 
methods [3]. These methods can be divided into 2 
main categories: linear probe methods and sequenc-
ing methods. The first are GeneXpert MTB / RIF (Ce-
pheid, USA) and Hain MTBDR (Hain Life Sciences, 
Germany) [4], which have received worldwide dis-
tribution due to their high sensitivity, specificity and 
economic efficiency. Sequencing methods, despite 
their higher sensitivity and specificity, have not been 
so widely used because of their high cost, which pre-
vents their widespread use in countries with a high 
tuberculosis burden as part of national tuberculosis 
control strategies.
The Hain test uses hybridization technology to 
detect mutations associated with MTB resistance to 
both the first and second line drugs. Detection of cer-
tain mutations in the rpoB gene corresponds to sus-
pected resistance to rifampicin (R), katG and inhA to 
isoniazid (H), gyrA and gyrB to fluoroquinolones (Q, 
in particular to levofloxacin (Lfx) and moxifloxacin 
(Mfx)), rrs and eis - to aminoglycosides.
Earlier studies, systematized in two meta-ana-
lyzes [5, 6], noted a wide variation in the sensitivity 
of this method from 96% (for R) to 44% (for kana-
mycin (Km)) and specificity from 99% (for H, R, Km 
and amikacin (Am)) up to 79% (for ethambutol). Due 
to this variation in the diagnostic value of molecular 
genetic diagnostic methods, culture tests remain the 
gold standard for determining the drug resistance of 
tuberculosis.
This study was performed to evaluate sensitivity 
and specificity of molecular-genetic diagnostic meth-
od Hain MTBDR in comparison to cultural methods 
of determining M. tuberculosis drug resistance.
Materials and methods. 3527 sputum speci-
mens from TB patients were investigated by Hain 
MTBDR and cultural methods (BACTEC and solid 
Lowenstein-Jensen medium) during 2018-2019. Hain 
MTBDR was used to determine resistance to R (de-
letions and mutations in the rpoB gene), H (deletions 
and mutations in the katG and inhA genes), Q (de-
letions and mutations in the gyrA and gyrB genes) 
and aminoglycosides (deletions and mutations in the 
rrs, eis genes ). The results obtained when performing 
culture tests and Hain MTBDR were compared with 
each other. Statistical data processing was performed 
using Microsoft Office Excel 2010 and Statistica 8.0.
Results. Among sputum samples, 25 inconsisten-
cies were found between the results of Hain MTBDR 
and culture tests, which accounted for 0.7% of all the 
studies performed (Table 1). 
From the data obtained it is clear that most of the 
differences in the results of molecular genetic and 
culture tests (12 cases) accounted for the determina-
tion of resistance to fluoroquinolones. Of these, in 10 
cases, mutations were found in the gyrA gene, cor-
responding to resistance to fluoroquinolones, which 
subsequently was not confirmed phenotypically by 
using culture drug susceptibility tests.
The false negative Hain MTBDR results, that 
is, the absence of detected mutations responsible for 
drug resistance combined with phenotypical detec-
tion of mutations, were observed mainly in the diag-
nosis of H resistance (4 cases) and aminoglycosides 
(Km - 3 cases, Cm - 3 cases).
The sensitivity of Hain MTBDR in this study was 
99.7%, and specificity was 99.6%. 
Discussion. The Hain MTBDR method is be-
coming more and more popular in bacteriological 
laboratories of tuberculosis institutions, since it has 
a sufficiently high sensitivity and specificity and can 
quickly detect the resistance of MTB to anti-tubercu-
losis drugs.
The sensitivity and specificity of the Hain MTB-
DR method in this study was higher compared with 
the results obtained in the studies of Feng et al. (2013) 
and Bai et al. (2016) [5-6], however, this may be as-
sociated with a significantly smaller number of tests 
carried out than in two meta-analyzes.
The omission of resistance to H may be due to the 
fact that Hain MTBDR does not determine the S315N 
mutation, which, meanwhile, occurs in almost a quar-
ter (23.8%) of H-resistant MTB [7].
The omission of aminoglycoside resistance can 
be explained by the same reason. Detection of mu-
tations in the eis and rrs genes provides a high level 
of specificity of the study and a sufficient level of its 
sensitivity [5, 6], however, mutations encoding resis-
tance to aminoglycosides may be contained in other 
genes not identified by Hain MTBDR, in particular, 
gidB [11] .
Preservation of sensitivity to fluoroquinolones 
even in the presence of mutations in the GyrA gene 
was also demonstrated in a number of studies [8–10], 
where it was suggested that substitution of C-8-me-
thoxy and C-8 halogen in the chemical structure of 
the new generation of fluoroquinolones (levofloxacin 
and moxifloxacin) provides their higher bactericidal 
and bacteriostatic efficacy with a lower minimum 
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inhibitory concentration, therefore mutations in the 
GyrA gene can provide resistance to these fluoro-
quinolones only in low concentrations, whereas in 
the standard dosage their antimicrobial activity will 
be maintained.
Conclusions. Hain MTBDR is a fast, highly 
sensitive, highly specific and relatively economical 
method for diagnosing drug resistance of M. tubercu-
losis. A small percentage of differences between the 
results of molecular genetic and phenotypic (cultural) 
Table 1. 
Comparison of Hain MTBDR and culture tests results
Drug Hain MTBDR Mutations Number of cases Culture tests
R resistant deletion wt8 in rpoB 
gene
1 sensitive
Н sensitive - 4 resistant
Q
sensitive
- 1 resistant to Lfx
- 1 resistant to Lfx, Mfx
resistant deletion wt2 and mu-
tation MUT2 in gyrA 
gene
1 resistant to Lfx
deletion wt2 and mu-
tation MUT2 in gyrA 
gene
1 sensitive to Lfx, Mfx
deletion wt2 and mu-
tation MUT1 in gyrA 
gene
3 sensitive to Lfx, Mfx
deletion wt3 in gyrA 
gene
1 sensitive to Lfx
deletion wt3 in gyrA 
gene
1 sensitive to Lfx, Mfx
deletion wt3 and mu-
tation MUT3C in gyrA 
gene
1 sensitive to Lfx
deletion wt3 and mu-
tation MUT3C in gyrA 
gene
1 sensitive to Lfx, Mfx
deletion wt3 and mu-
tation MUT3A in gyrA 
gene
1 sensitive to Lfx, Mfx
Km sensitive - 3 resistant
resistant deletion wt2 in eis gene 1 sensitive
Cm sensitive - 3 resistant
resistant mutation MUT1 in rrs 
gene
1 sensitive
research methods can be explained by the fact that 
Hain MTBDR does not detect rare mutations that de-
termine resistance to anti-tuberculosis drugs, as well 
as the fact that mutations in the gyrA gene with the 
introduction of a new generation of fluoroquinolones 
detect resistance to low concentrations of drugs only. 
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